Haleos Labs Limited vs Unichem Laboratories Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: May 03, 2026

Key Highlights

The Latest Trading Price of Haleos Labs Limited is ₹ 1474 as of 30 Apr 15:30 . The P/E Ratio of Haleos Labs Limited changed from 11 on March 2021 to 16.2 on March 2025 . This represents a CAGR of 8.05% over 5 yearsThe P/E Ratio of Unichem Laboratories Ltd changed from 63.4 on March 2021 to 35.5 on March 2025 . This represents a CAGR of -10.95% over 5 years The Market Cap of Haleos Labs Limited changed from ₹ 149.61 crore on March 2021 to ₹ 326.64 crore on March 2025 . This represents a CAGR of 16.90% over 5 yearsThe Market Cap of Unichem Laboratories Ltd changed from ₹ 2177 crore on March 2021 to ₹ 4877 crore on March 2025 . This represents a CAGR of 17.50% over 5 years The revenue of Haleos Labs Limited for the Dec '25 is ₹ 94.97 crore as compare to the Sep '25 revenue of ₹ 81.79 crore. This represent the growth of 16.11% The revenue of Unichem Laboratories Ltd for the Dec '25 is ₹ 808.49 crore as compare to the Sep '25 revenue of ₹ 599.93 crore. This represent the growth of 34.76% The ebitda of Haleos Labs Limited for the Dec '25 is ₹ 14.23 crore as compare to the Sep '25 ebitda of ₹ 13.99 crore. This represent the growth of 1.72% The ebitda of Unichem Laboratories Ltd for the Dec '25 is ₹ 332.1 crore as compare to the Sep '25 ebitda of ₹ 28.89 crore. This represent the growth of 1049% The net profit of Haleos Labs Limited changed from ₹ 7.1 crore to ₹ 6.65 crore over 7 quarters. This represents a CAGR of -3.67% The net profit of Unichem Laboratories Ltd changed from ₹ 2.07 crore to ₹ 264.29 crore over 7 quarters. This represents a CAGR of 1497.69% The Dividend Payout of Haleos Labs Limited changed from 3.44 % on March 2021 to 2.12 % on March 2025 . This represents a CAGR of -9.23% over 5 yearsThe Dividend Payout of Unichem Laboratories Ltd changed from 52.07 % on March 2021 to 0 % on March 2025 . This represents a CAGR of -100.00% over 5 years .

About Haleos Labs Limited

SMS Lifesciences India Limited was incorporated originally as 'Potluri Real Estate Private Limited' on May 31, 2006.
The Company's name was changed to 'Potluri Packaging Industries Private Limited' on 6 November, 2013 and again changed to 'SMS Lifesciences India Private Limited on 4 August, 2014 to undertake the activities related pharma sector.
The Company became a wholly owned subsidiary Company of SMS Pharmaceuticals Limited w.e.f. 01.04.2016 and subsequently got converted into a Public Limited w.e.f. 22 June, 2016. The Company is engaged in the business of manufacturing and export of Active Pharma Ingredients(APIs) and their intermediates.
The Company is having manufacturing facilities at Kazipally and Jeedimetla, Hyderabad with an installed capacity of 65 KL. What started off as a single facility - single product manufacturing company in 1990 grew to be a multi-location group having products spread across an array of therapeutic segments.

About Unichem Laboratories Ltd

Unichem Laboratories Limited manufactures active pharmaceutical ingredients.
The company operates through four divisions, namely Unichem Pharma Division, Unichem Specialities Division, Unisearch Division and Neu-Foreva Division.
The company is headquartered in Mumbai with five manufacturing facilities located at Roha in Maharashtra, Goa, Ghaziabad in Uttar Pradesh, Pithampur in Madhya Pradesh and Baddi in Himachal Pradesh. The company's facilities enjoy credible certifications, the Goa plant was approved by UK MHRA, MCC (South Africa), WHO (Geneva) and TGA (Australia).
The Baddi plant was approved by UK MHRA and MCC (South Africa).
The company received ISO 9001:2000 for all their plants and corporate office.

FAQs for the comparison of Haleos Labs Limited and Unichem Laboratories Ltd

Which company has a larger market capitalization, Haleos Labs Limited or Unichem Laboratories Ltd?

Market cap of Haleos Labs Limited is 445 Cr while Market cap of Unichem Laboratories Ltd is 2,740 Cr

What are the key factors driving the stock performance of Haleos Labs Limited and Unichem Laboratories Ltd?

The stock performance of Haleos Labs Limited and Unichem Laboratories Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Haleos Labs Limited and Unichem Laboratories Ltd?

As of May 3, 2026, the Haleos Labs Limited stock price is INR ₹1474.9. On the other hand, Unichem Laboratories Ltd stock price is INR ₹389.3.

How do dividend payouts of Haleos Labs Limited and Unichem Laboratories Ltd compare?

To compare the dividend payouts of Haleos Labs Limited and Unichem Laboratories Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.